Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University Medical Center Goettingen clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Germany register with University Medical Center Goettingen as lead sponsor. Synced 14 Nov 2026
18Current trials
14Recruiting now
0Drugs in these trials
1Trial register
At a glance

University Medical Center Goettingen is the lead sponsor of 18 current clinical trials in our Germany register. 14 are recruiting patients now. The most common phase is Observational. The most-studied condition is CMT (Charcot Marie Tooth Disease).

ClinicalTrials.gov trials by status

  • Recruiting1478%
  • Not yet open16%
  • By invitation317%

Trials by phase

  • Observational1478%
  • Not applicable317%
  • Phase 1/216%
01

Clinical trials sponsored by University Medical Center Goettingen

18 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set
NCT07505498 · ClinicalTrials.gov ↗ · Patient Related Outcome Measures, Supportive Care, Patient Reported Outcome (PRO)
Observational Recruiting 2025-12 Germany
Safety and Efficacy of Induced Pluripotent Stem Cell-derived Engineered Human Myocardium as Biological Ventricular Assist Tissue in Terminal Heart Failure
NCT04396899 · ClinicalTrials.gov ↗ · Heart Failure
Phase 1/2 Recruiting 2020-02 Germany
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
NCT06526065 · ClinicalTrials.gov ↗ · DLBCL - Diffuse Large B Cell Lymphoma
Observational Recruiting 2024-06 Germany
CABP2 Patient Registry and Natural History Study
NCT06680934 · ClinicalTrials.gov ↗ · CABP2-related Auditory Synaptopathy, Hearing Impairment
Observational Recruiting 2024-08 Germany
Prediction of Heart-Failure with Machine Learning
NCT06819618 · ClinicalTrials.gov ↗ · Heart Failure with Reduced Ejection Fraction, Heart Failure, Heart Failure,Congestive
Observational Recruiting 2024-04 Germany
Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases
NCT07135817 · ClinicalTrials.gov ↗ · Spinal Metastases, Solid Tumor Cancer
Not applicable Recruiting 2025-08 Germany
Orofacial Pain and Oral Health-Related Quality of Life in Musicians in German Amateur Orchestras
NCT07714837 · ClinicalTrials.gov ↗ · Orofacial Pain, Sleep Bruxism, Oral Health Related Quality of Life (OHRQoL)
Observational Recruiting 2026-09 Germany
Pancreatitis - Microbiome as Predictor of Severity II
NCT06508502 · ClinicalTrials.gov ↗ · Acute Pancreatitis, Acute Pancreatitis With Infected Necrosis
Observational Recruiting 2024-05 Germany
A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)
NCT07476365 · ClinicalTrials.gov ↗ · CMT, CMT (Charcot Marie Tooth Disease), CMT - Charcot-Marie-Tooth Disease
Observational Recruiting 2025-03 Germany
AUTONOMOUS DISORDERS IN CMT
NCT07570446 · ClinicalTrials.gov ↗ · CMT - Charcot-Marie-Tooth Disease, CMT1A, CMT (Charcot Marie Tooth Disease)
Observational Recruiting 2024-07 Germany
Pelvic Cancer Registry for Online Adapted Radiotherapy
NCT06185062 · ClinicalTrials.gov ↗ · Pelvic Tumor, Thoracic Tumor
Observational Recruiting 2024-01 Germany
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
NCT06208007 · ClinicalTrials.gov ↗ · Heart Failure With Preserved Ejection Fraction, Cardiovascular Morbidity
Observational Recruiting 2024-02 Germany
Longitudinal Biomarkers With Selected Outcome Measures In CMT
NCT06794489 · ClinicalTrials.gov ↗ · CMT1A, CMT (Charcot Marie Tooth Disease), CMT 1A
Observational Recruiting 2024-11 Germany
TREMOR IN CHARCOT-MARIE-TOOTH
NCT07570459 · ClinicalTrials.gov ↗ · CMT, CMT (Charcot Marie Tooth Disease), Charcot Marie Tooth Disease (CMT)
Observational Recruiting 2024-07 Germany
Simulation-Based Patient Education to Address Radiotherapy-Related Anxiety in Cancer Patients (ARAISE)
NCT07721246 · ClinicalTrials.gov ↗ · Neoplasms, Anxiety
Not applicable Not yet open 2028-01 Germany
Real-time Acoustic Biofeedback for Enhancing Fixation Stability: A Proof-of-concept Study to Improve Ophthalmic Imaging Diagnostic Quality
NCT07529041 · ClinicalTrials.gov ↗ · Retinal Dystrophies, Geographic Atrophy, Blindness
Not applicable By invitation 2025-08 Germany
FINancial Toxicity and CAncer REcovery in YOUNG Adults
NCT07314801 · ClinicalTrials.gov ↗ · Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults
Observational By invitation 2025-12 Germany
Prospective Exploratory Cohort Study on Ganglion Cell Degeneration in Retinitis Pigmentosa Patients
NCT07056738 · ClinicalTrials.gov ↗ · Retinitis Pigmentosa
Observational By invitation 2025-03 Germany

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in University Medical Center Goettingen trials

35 conditions
CMT (Charcot Marie Tooth Disease)4CMT - Charcot-Marie-Tooth Disease3CMT1A3Heart Failure2CMT2Patient Related Outcome Measures1Supportive Care1Patient Reported Outcome (PRO)1Retinal Dystrophies1Geographic Atrophy1Blindness1DLBCL - Diffuse Large B Cell Lymphoma1CABP2-related Auditory Synaptopathy1Hearing Impairment1Heart Failure with Reduced Ejection Fraction1Heart Failure,Congestive1Heart Failure Acute1Spinal Metastases1Solid Tumor Cancer1Orofacial Pain1Sleep Bruxism1Oral Health Related Quality of Life (OHRQoL)1Acute Pancreatitis1Acute Pancreatitis With Infected Necrosis1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Germany1814

A trial with sites in more than one country appears in each of those registers.

04

Questions about University Medical Center Goettingen trials

How many clinical trials does University Medical Center Goettingen sponsor?

University Medical Center Goettingen is the lead sponsor of 18 current trials on ClinicalTrials.gov in our Germany register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.

Are University Medical Center Goettingen trials recruiting?

Yes. 14 of its 18 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.